Table 1 Patient characteristics
Chemoradiation (N = 227) | Chemotherapy (N = 82) | P | |
|---|---|---|---|
Age at diagnosis – years | 0.124 | ||
Median | 58.71 | 56.51 | |
Range | 30 - 80 | 34 - 75 | |
Sex - No. (%) | 0.964 | ||
Male | 135 (59.5) | 49 (59.8) | |
Female | 92 (40.5) | 33 (40.2) | |
ECOG Performance status - No. (%) | 0.401 | ||
0 | 97 (42.7) | 38 (46) | |
1 | 112 (49.3) | 38 (46.3) | |
2 | 18 (7.9) | 5 (6.1) | |
3 | 0 (0.0) | 1 (1.2) | |
Histology - No. (%) | 0.712 | ||
Diffuse/signet ring | 97 (42.7) | 34 (41.5) | |
Tubular/intestinal | 90 (39.6) | 35 (42.7) | |
Not specified | 40 (17.6) | 13 (15.9) | |
TNM Stage group - No. (%) | 0.021 | ||
IB | 11 (4.8) | 3 (3.7) | |
IIA | 54 (23.8) | 10 (12.2) | |
IIB | 43 (18.9) | 13 (15.9) | |
IIIA | 41 (18.1) | 10 (12.2) | |
IIIB | 42 (18.5) | 22 (26.8) | |
IIIC | 36 (15.9) | 24 (29.3) | |
Lymph node dissection - No. (%) | 0.273 | ||
D1 | 61 (26.9) | 17 (20.7) | |
D2 | 166 (73.1) | 65 (79.3) | |
Surgical margin - No. (%) | 0.359 | ||
R0 | 207 (91.2) | 72 (87.8) | |
R1 | 18 (7.9) | 10 (12.2) | |
R2 | 2 (0.9) | 0 (0.0) |